AAI

Accelerating Access Initiative

AIDS

Acquired immune deficiency syndrome

ARIPO

African Regional Industrial Property Organization

ART

Antiretroviral therapy

ARV

Antiretroviral

BI

Boehringer Ingelheim

BMS

Bristol-Myers Squibb

CIF

Cost, insurance, freight

DT

Delivery time

EML

Essential medicines list

FDC

Fixed-dose combination

GMP

Good manufacturing practices

GSK

GlaxoSmithKline

HIV

Human immunonodeficiency virus

ICH

International Conference for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

LDC

Least developed country

Merck & Co

Merck, Sharp & Dohme

MSF

M decins Sans Frontires

NDRA

National drug regulatory authority

OAPI

African Organization of Intellectual Property (L'Organisation Africaine de la Propriété Intellectuelle)

NGO

Non-governmental organization

PLWHA

People living with HIV/AIDS

PMTCT

Prevention of mother-to-child-transmission

Ppy

per patient per year

RIA

Registered import advice

TB

Tuberculocis

TRIPS

Trade-Related Aspects of Intellectual Property Rights

UNAIDS

Joint United Nations Programme on HIV/AIDS

UNCTAD

United Nations Conference on Trade and Development

UNDP

United Nations Development Programme

UNFPA

United Nations Population Fund

UNICEF

United Nations Children's Fund

VAT

Value added tax

WHO

World Health Organization

WIPO

World Intellectual Property Rights Organization

WTO

World Trade Organization

3TC

lamivudine (Epivir®); nucleoside analogue reverse transcriptase inhibitor

ABC

abacavir (Ziagen®); nucleoside analogue reverse transcriptase inhibitor

d4T

stavudine (Zerit®); nucleoside analogue reverse transcriptase inhibitor

ddI

didanosine (Videx®): nucleoside analogue reverse transcriptase inhibitor

(AZT or)

zidovudine (Retrovir®): nucleoside analogue reverse

ZDV

transcriptase inhibitor

NVP

nevirapine (Viramune®): non-nucleoside analogue reverse transcriptase inhibitor

EFV

efiravenz (Stocrin®): non-nucleoside analogue reverse transcriptase inhibitor

NFV

nelfinavir (Viracept®): protease inhibitor

LPV/r

lopinavir/ritonavir (Kaletra¨): protease inhibitor

TDF

tenofovir (Viread®): nucleotide reverse transriptase inhibitor

IDV

indinavir (Crixivan®): protease inhibitor

r

ritonavir (Norvir®): low dose ritonavir used as a booster; protease inhibitor

SQV

saquinavir (Invirase®): protease inhibitor

ddC

zalcitabine (Hivid®): nucleotide reverse transriptase inhibitor